The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Using 'biased-privileged' scaffolds to identify lysine methyltransferase inhibitors.EBI
Rockefeller University
Comparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole.EBI
Rockefeller University
Pharmacological inhibitors of glycogen synthase kinase 3.EBI
Rockefeller University
Probing cell-division phenotype space and Polo-like kinase function using small molecules.EBI
Rockefeller University
Discovery of protein phosphatase 2C inhibitors by virtual screening.EBI
Rockefeller University
N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITSBDB
Eurofarma
Inhibitors of KRAS G12C and methods of using the sameBDB
Amgen
Purine inhibitors of human phosphatidylinositol 3-kinase deltaBDB
Merck Sharp & Dohme
Bruton's tyrosine kinase inhibitorsBDB
Suzhou Baijibugong Pharmaceutical Technology
Heterocyclic compounds and uses thereofBDB
Plexxikon
1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI).BDB
Glaxosmithkline